Canada’s Drug Agency/L’Agence des médicaments du Canada (CDA-AMC) recently launched a strategy to advance the appropriate use of prescription drugs and related products in Canada. According to the CDA-AMC, 1.9 million Canadian seniors regularly use at least 1
Canada’s Drug Agency/L’Agence des médicaments du Canada (CDA-AMC) has launched a consultation on advice for a national bulk purchasing strategy for prescription drugs and related products. Notably, the advice proposes making the pan-Canadian Pharmaceutical Alliance (pCPA)
On June 19, 2025, Canada’s Drug Agency/L’Agence des médicaments du Canada (CDA-AMC) announced a consultation on a proposed list of essential prescription drugs and related products intended to inform the development of a national formulary. The consultation is